Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment to hereditary cancer risk assessment and genetic testing during National Colorectal Cancer Awareness Month.
Original Article: Myriad Genetics shows strong commitment, support in the fight against colorectal cancer